Table 2.
Parameter | Patients without Fixed Reduction in Segmental Systolic Reduction |
Patients with Fixed Reduction in Segmental Systolic Reduction |
||||||
---|---|---|---|---|---|---|---|---|
Baseline |
Follow-Up |
Baseline |
Follow-Up |
|||||
Pre-HD | Post-HD | Pre-HD | Post-HD | Pre-HD | Post-HD | Pre-HD | Post-HD | |
Hemoglobin (g/dl) | 10.8 ± 1.1 | 11.3 ± 1.0 | 11.8 ± 1.7 | 12.2 ± 1.8 | 11.2 ± 1.5 | 11.7 ± 1.6 | 11.9 ± 1.6 | 12.2 ± 1.7 |
Sodium (mmol/L) | 137 ± 3 | 137 ± 2 | 136 ± 4 | 137 ± 2 | 138 ± 3 | 138 ± 2 | 137 ± 4 | 137 ± 3 |
Potassium (mmol/L) | 4.3 ± 0.5 | 2.8 ± 0.5 | 4.4 ± 0.8 | 2.8 ± 0.4 | 4.9 ± 1.0 | 2.9 ± 0.4 | 4.6 ± 0.1 | 3.0 ± 0.7 |
Urea (mmol/L) | 19.6 ± 4.7 | 5.8 ± 2.1 | 17.8 ± 5.6 | 5.4 ± 2.4 | 21 ± 4.6 | 6.5 ± 2.2 | 23.3 ± 8.7 | 7.0 ± 2.9 |
Creatinine (μmol/L) | 665 ± 165 | 258 ± 74 | 618 ± 165 | 250 ± 87 | 658 ± 213 | 267 ± 107 | 725 ± 257 | 300 ± 148 |
Phosphate (mmol/L) | 1.8 ± 0.4 | 0.8 ± 0.1 | 1.7 ± 0.5 | 0.7 ± 0.2 | 1.5 ± 0.5 | 0.8 ± 0.3 | 1.8 ± 0.6 | 0.8 ± 0.3 |
Bicarbonate (mmol/L) | 23.8 ± 1.9 | 27.1 ± 4.1 | 22.8 ± 2.2 | 27 ± 1.6 | 23.1 ± 2.5 | 27.9 ± 2.4 | 24.2 ± 2.6 | 26.8 ± 1.7 |
Corrected calcium (mmol/L) | 2.4 ± 0.2 | 2.3 ± 0.1 | 2.4 ± 0.1 | 2.3 ± 0.1 | 2.4 ± 0.1 | 2.4 ± 0.1 | 2.4 ± 0.2 | 2.3 ± 0.1 |
Albumin (g/L) | 34.4 ± 2.9 | 35.8 ± 3.8 | 30.6 ± 6.2 | 32.3 ± 7.4 | 35.3 ± 4.7 | 36.6 ± 5.5 | 35.2 ± 4.4 | 37.1 ± 4.9 |
cTnT (μg/L) | 0.07 ± 0.05 | – | 0.12 ± 0.12 | – | 0.09 ± 0.06 | – | 0.08 ± 0.05 | – |
Kt/Vurea | 1.3 ± 0.2 | – | 1.4 ± 0.2 | – | 1.3 ± 0.3 | – | 1.3 ± 0.4 | – |
There were no significant differences between different or within the same groups at either time point (P > 0.1).